Kensuke Joh1, Eri Muso2, Hidekazu Shigematsu3, Masato Nose4, Michio Nagata5, Yoshihiro Arimura6, Wako Yumura7, Takashi Wada8, Kousaku Nitta9, Hirofumi Makino10, Yoshio Taguma11, Hidetoshi Kaneoka12, Yuhsuke Suzuki13, Masaki Kobayashi14, Akio Koyama15, Joichi Usui16, Hiroshi Hashimoto17, Shoichi Ozaki18, Yasuhiko Tomino13, Kunihiro Yamagata16. 1. Division of Renal Pathology, Clinical Research Center, Chiba-East National Hospital, Chiba, Japan. johken@cehprinet.com. 2. Division of Nephrology, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan. 3. Department of Pathology, Shinshu University School of Medicine, Matsumoto, Japan. 4. Department of Pathogenomics, Ehime University Graduate School of Medicine, Ehime, Japan. 5. Department of Molecular Pathology, Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan. 6. First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan. 7. Department of Nephrology and Kidney Center, Department of Medicine, Jichi Medical University, Tochigi, Japan. 8. Department of Laboratory Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan. 9. Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan. 10. Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. 11. Department of Nephrology, Sendai Shakaihoken Hospital, Miyagi, Japan. 12. Department of Medical Nursing, Fukuoka University School of Nursing, Fukuoka, Japan. 13. Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. 14. Department of Internal Medicine, Tokyo Medical University, Kasumigaura Hospital, Ibaraki, Japan. 15. Ibaraki Prefectural University of Health Science, Ibaraki, Japan. 16. Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan. 17. Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. 18. Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Abstract
BACKGROUND: In Japan, systematic evaluation of the histologic parameters of anti-neutrophil cytoplasmic autoantibodies (ANCA)-related vasculitis has been performed according to the Japanese classification by Shigematsu et al. However, this classification is quite different from that of the European Vasculitis Study Group (EUVAS) classification. Therefore, a histological common basis is needed to compare Japanese histological data with the international database. METHOD: Histological parameters concerning glomerular, tubulointerstitial, and vascular lesions of ANCA-related vasculitis, which are indispensable for clinical management, were elucidated and defined by reviewing, utilizing the merits of, and amending the two scoring systems. RESULTS AND CONCLUSION: A new comprehensive and standardized scoring system, by which histological quantitative assessment can provide evidence for therapy planning, has been developed for renal biopsy of Japanese ANCA-related vasculitis.
BACKGROUND: In Japan, systematic evaluation of the histologic parameters of anti-neutrophil cytoplasmic autoantibodies (ANCA)-related vasculitis has been performed according to the Japanese classification by Shigematsu et al. However, this classification is quite different from that of the European Vasculitis Study Group (EUVAS) classification. Therefore, a histological common basis is needed to compare Japanese histological data with the international database. METHOD: Histological parameters concerning glomerular, tubulointerstitial, and vascular lesions of ANCA-related vasculitis, which are indispensable for clinical management, were elucidated and defined by reviewing, utilizing the merits of, and amending the two scoring systems. RESULTS AND CONCLUSION: A new comprehensive and standardized scoring system, by which histological quantitative assessment can provide evidence for therapy planning, has been developed for renal biopsy of Japanese ANCA-related vasculitis.
Authors: Herbert A Hauer; Ingeborg M Bajema; Hans C van Houwelingen; Franco Ferrario; Laure-Hélène Noël; Rüdiger Waldherr; David R W Jayne; Niels Rasmussen; Jan A Bruijn; E Christiaan Hagen Journal: Kidney Int Date: 2002-01 Impact factor: 10.612
Authors: I M Bajema; E C Hagen; B E Hansen; J Hermans; L H Noël; R Waldherr; F Ferrario; F J van der Woude; J A Bruijn Journal: Nephrol Dial Transplant Date: 1996-10 Impact factor: 5.992
Authors: Robert A F de Lind van Wijngaarden; Herbert A Hauer; Ron Wolterbeek; David R W Jayne; Gill Gaskin; Niels Rasmussen; Laure-Hélène Noël; Franco Ferrario; Rüdiger Waldherr; E Christiaan Hagen; Jan A Bruijn; Ingeborg M Bajema Journal: J Am Soc Nephrol Date: 2006-07-06 Impact factor: 10.121
Authors: L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse Journal: Arthritis Rheum Date: 1999-03
Authors: Anthony D Booth; Mike K Almond; Aine Burns; Peter Ellis; Gill Gaskin; Guy H Neild; Martin Plaisance; Charles D Pusey; David R W Jayne Journal: Am J Kidney Dis Date: 2003-04 Impact factor: 8.860
Authors: David Jayne; Niels Rasmussen; Konrad Andrassy; Paul Bacon; Jan Willem Cohen Tervaert; Jolanta Dadoniené; Agneta Ekstrand; Gill Gaskin; Gina Gregorini; Kirsten de Groot; Wolfgang Gross; E Christiaan Hagen; Eduardo Mirapeix; Erna Pettersson; Carl Siegert; Alberto Sinico; Vladimir Tesar; Kerstin Westman; Charles Pusey Journal: N Engl J Med Date: 2003-07-03 Impact factor: 91.245